Financials Aquarius Surgical Technologies Inc.
Equities
ASTI
CA03842P1009
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 CAD | 0.00% |
|
0.00% | +100.00% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 7.293 | 4.109 | 8.003 | 4.847 | 1.658 | 0.276 |
Enterprise Value (EV) 1 | 8.176 | 5.999 | 9.923 | 7.627 | 4.742 | 3.664 |
P/E ratio | -1.14 x | -2.55 x | -4.63 x | -2.66 x | -1.93 x | -0.38 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 7.48 x | 10.4 x | 8.35 x | 8.31 x | 5.06 x | 1.35 x |
EV / Revenue | 8.39 x | 15.2 x | 10.3 x | 13.1 x | 14.5 x | 18 x |
EV / EBITDA | -5.73 x | -4.78 x | -8.38 x | -11.6 x | -7.45 x | -5.69 x |
EV / FCF | -8.84 x | -4.6 x | -13.9 x | -20.9 x | 164 x | -59.8 x |
FCF Yield | -11.3% | -21.7% | -7.19% | -4.78% | 0.61% | -1.67% |
Price to Book | 56.7 x | -9.05 x | -11.6 x | -2.02 x | -0.52 x | -0.07 x |
Nbr of stocks (in thousands) | 18,234 | 19,566 | 22,867 | 23,079 | 23,679 | 27,599 |
Reference price 2 | 0.4000 | 0.2100 | 0.3500 | 0.2100 | 0.0700 | 0.0100 |
Announcement Date | 10/08/18 | 30/07/19 | 14/08/20 | 16/08/21 | 02/08/22 | 03/08/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 0.9745 | 0.3934 | 0.9587 | 0.5834 | 0.3277 | 0.2037 |
EBITDA 1 | -1.428 | -1.256 | -1.184 | -0.6572 | -0.6363 | -0.6439 |
EBIT 1 | -1.919 | -1.373 | -1.315 | -0.7928 | -0.6874 | -0.6517 |
Operating Margin | -196.91% | -349.03% | -137.12% | -135.88% | -209.79% | -319.89% |
Earnings before Tax (EBT) 1 | -7.402 | -1.587 | -1.611 | -1.81 | -0.8592 | -0.7234 |
Net income 1 | -6.252 | -1.587 | -1.611 | -1.81 | -0.8592 | -0.7234 |
Net margin | -641.52% | -403.35% | -168% | -310.3% | -262.22% | -355.09% |
EPS 2 | -0.3496 | -0.0822 | -0.0755 | -0.0789 | -0.0363 | -0.0262 |
Free Cash Flow 1 | -0.9253 | -1.304 | -0.7133 | -0.3649 | 0.0289 | -0.0613 |
FCF margin | -94.95% | -331.56% | -74.4% | -62.53% | 8.81% | -30.09% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 10/08/18 | 30/07/19 | 14/08/20 | 16/08/21 | 02/08/22 | 03/08/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 0.88 | 1.89 | 1.92 | 2.78 | 3.08 | 3.39 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | -0.618 x | -1.505 x | -1.622 x | -4.23 x | -4.847 x | -5.262 x |
Free Cash Flow 1 | -0.93 | -1.3 | -0.71 | -0.36 | 0.03 | -0.06 |
ROE (net income / shareholders' equity) | -243% | 976% | 282% | 117% | 30.6% | 20.5% |
ROA (Net income/ Total Assets) | -24% | -51.4% | -48.6% | -38% | -46.7% | -51.7% |
Assets 1 | 26.09 | 3.084 | 3.316 | 4.759 | 1.841 | 1.399 |
Book Value Per Share 2 | 0.0100 | -0.0200 | -0.0300 | -0.1000 | -0.1400 | -0.1400 |
Cash Flow per Share 2 | 0.0100 | 0.0100 | 0 | 0.0100 | 0.0100 | 0 |
Capex 1 | 0.03 | 0.82 | 0.12 | 0.1 | 0.01 | - |
Capex / Sales | 3.44% | 208.08% | 12.84% | 17.14% | 1.59% | - |
Announcement Date | 10/08/18 | 30/07/19 | 14/08/20 | 16/08/21 | 02/08/22 | 03/08/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+100.00% | 403K | |
+6.37% | 216B | |
+10.21% | 189B | |
+28.22% | 153B | |
+34.42% | 114B | |
+0.80% | 63.2B | |
+19.21% | 54.78B | |
+0.13% | 48.47B | |
-4.16% | 38.88B | |
+2.39% | 36.14B |
- Stock Market
- Equities
- ASTI Stock
- Financials Aquarius Surgical Technologies Inc.